Target intelligence / Profile preview

Fungal cell growth

Molecular classification
Other
01

Overview

Fungal cell growth" refers to the process by which fungal cells, including yeasts and filamentous fungi, increase in size, proliferate, and develop specialized structures such as hyphae and spores[6][7][14][15]. This process is driven by tightly regulated mechanisms involving the synthesis of the cell wall and membrane, cell cycle progression, vesicle transport, and polarized growth[9][13][15]. Key molecular components include chitin, β-glucans, and various enzymes for their synthesis, as well as cyclin-dependent kinases and actin cytoskeleton elements that control cell division and morphogenesis[2][9][12]. The unique aspects of fungal cell growth (such as cell wall composition and growth polarity) are critical for fungal pathogenicity and are the target of most antifungal drugs[1][12]. However, "fungal cell growth" itself is a collective term for these underlying processes and molecules, rather than a discrete molecular entity or direct drug target[1]. There is an error in the consideration of "fungal cell growth" as a target—this is a process, not a specific molecule, receptor, enzyme, or protein. For structured therapeutic target information, individual molecules such as "β-1,3-glucan synthase" or "ergosterol synthesis enzymes" should be specified instead[1][9][12].

Other names
Fungal growthMycelial growthHyphal growthYeast growthFungal proliferation
02

Mechanism of action

Inhibition of ergosterol biosynthesis (azoles, allylamines), Disruption of cell wall synthesis (echinocandins), Binding to ergosterol to disrupt membranes (polyenes), Inhibition of nucleic acid synthesis (flucytosine)

03

Biological functions

Cell proliferationMorphogenesisReproductionNutrient absorptionCell cycleCell wall synthesisPolarized growth
04

Disease associations

Infection (fungal infections in humans, animals, and plants)Other (related to agricultural spoilage, mycotoxicosis, etc.)
05

Safety considerations

Host toxicityemergence of resistancedrug–drug interactionslimited spectrum of activity (applies to antifungal drugs)
06

Interacting drugs

Azoles (e.g., fluconazole)

4 more in the full profile.

07

Biomarkers

β-D-glucan (fungal cell wall component)MannanGalactomannan (fungal antigens used in diagnostics)

Beyond the preview

Go deeper on Fungal cell growth.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal cell growth.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call